Target intelligence / Profile preview

Endogenous repair processes

Molecular classification
Other
01

Overview

Endogenous repair processes encompass the innate biological mechanisms used by the body to restore cellular and tissue homeostasis following injury, infection, or genetic damage (Nature Reviews Molecular Cell Biology, 2017). These processes include DNA repair pathways, such as base excision repair and homologous recombination, as well as tissue-level responses like the activation of resident stem cell populations and wound healing cascades (NIH, 2021). In many pathological states, including neurodegeneration and chronic heart failure, these natural repair mechanisms are either overwhelmed or suppressed by inhibitory microenvironments (Frontiers in Cell and Developmental Biology, 2020). Therapeutic interventions often aim to augment these processes by delivering growth factors, modulating epigenetic states, or inhibiting negative regulators of regeneration (PubMed, 2019). However, because these pathways are closely linked to cell cycle control, their therapeutic manipulation poses significant risks, most notably the potential for malignant transformation and uncontrolled cellular proliferation (StatPearls, 2023).

Other names
Endogenous regenerationInnate healing mechanismsSelf-repair processesTissue repair and regenerationEndogenous recovery
02

Mechanism of action

Enhancement of innate regenerative capacity through the activation of endogenous stem cells, modulation of growth factor signaling (e.g., VEGF, PDGF), or the inhibition of DNA repair enzymes to induce synthetic lethality in oncology.

03

Biological functions

Tissue regenerationDNA repairWound healingCell proliferationHomeostasisStem cell activation
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseCancerChronic woundsAgingIschemic stroke
05

Safety considerations

OncogenesisFibrosisHyperplasiaImmune system overactivationMaladaptive remodeling
06

Interacting drugs

Olaparib

5 more in the full profile.

07

Biomarkers

Ki-67Gamma-H2AXCD34+ progenitor cellsBrdU incorporationNestin

Beyond the preview

Go deeper on Endogenous repair processes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endogenous repair processes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call